• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconAstraZeneca

AstraZeneca

Page 8 of 13
Public health officials warn about slow vaccine rollout as coronavirus variants multiply
HealthPublic health officials warn about slow vaccine rollout as coronavirus variants multiply
By James Paton and BloombergJanuary 18, 2021
A photo of Jonas Salk injecting a boy with the polio vaccine he invented.
HealthThe COVID-19 vaccination drive may be slow—but it’s already faster than any in history
By Jeremy KahnJanuary 17, 2021
Sick patients over 80 could be a COVID vaccine risk, Norwegian health officials warn
HealthSick patients over 80 could be a COVID vaccine risk, Norwegian health officials warn
By Lars Erik Taraldsen, Naomi Kresge and BloombergJanuary 15, 2021
Drugmakers hit back at U.K. plan to delay the second dose of COVID vaccines
HealthDrugmakers hit back at U.K. plan to delay the second dose of COVID vaccines
By James Paton and BloombergJanuary 13, 2021
EU regulators approve Moderna’s COVID vaccine as pressure builds to speed up immunizations
HealthEU regulators approve Moderna’s COVID vaccine as pressure builds to speed up immunizations
By Naomi Kresge and BloombergJanuary 6, 2021
U.K. Prime Minister Boris Johnson holding a vial of AstraZeneca's Covid-19 vaccine.
HealthU.K. approves AstraZeneca COVID-19 vaccine
By Jeremy KahnDecember 30, 2020
AstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week
HealthAstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week
By Viren Vaghela, Thomas Penny and BloombergDecember 28, 2020
Why Wall Street is ‘signaling caution’ for your stock portfolio in 2021
NewslettersWhy Wall Street is ‘signaling caution’ for your stock portfolio in 2021
By Bernhard WarnerDecember 15, 2020
Photo of AstraZeneca CEO Pascal Soriot
FinanceWhy shareholders had a severe adverse reaction to AstraZeneca’s Alexion deal
By Jeremy KahnDecember 14, 2020
COVID vaccines are coming—but it might be too late for the housing market
NewslettersCOVID vaccines are coming—but it might be too late for the housing market
By Bernhard WarnerDecember 14, 2020
AstraZeneca acquires rare-disease specialist Alexion in $39 billion deal
HealthAstraZeneca acquires rare-disease specialist Alexion in $39 billion deal
By John Lauerman, James Paton and BloombergDecember 13, 2020
Who gets first dibs on a COVID-19 vaccine? The U.K.’s historic rollout today reveals who gets precedence
HealthWho gets first dibs on a COVID-19 vaccine? The U.K.’s historic rollout today reveals who gets precedence
By Katherine DunnDecember 8, 2020
The global rally stalls out, but Goldman Sachs is doubling down on value stocks
NewslettersThe global rally stalls out, but Goldman Sachs is doubling down on value stocks
By Bernhard WarnerDecember 7, 2020
Airlines are facing ‘mission of the century’ in shipping COVID vaccines
HealthAirlines are facing ‘mission of the century’ in shipping COVID vaccines
By Christopher Jasper, William Wilkes and BloombergNovember 30, 2020
AstraZeneca COVID-19 vaccine comes under scrutiny again, this time in India
AstraZeneca COVID-19 vaccine comes under scrutiny again, this time in India
By Naomi Xu ElegantNovember 30, 2020
1...
  • 6
  • 7
  • 8
  • 9
  • 10
...13
Most Popular
Economy
Jerome Powell says the $39 trillion national debt is ‘not unsustainable,’ but warns the trajectory ‘will not end well’placeholder alt text
By Fortune EditorsMarch 30, 2026
Success
Two-thirds of parents say their adult Gen Z kids still rely on them financially  for support—even though it's putting them under strainplaceholder alt text
By Fortune EditorsMarch 31, 2026
AI
A man used AI to call 3,000 Irish bartenders to track the cost of Guinness. Now pubs are lowering their prices to competeplaceholder alt text
By Fortune EditorsMarch 30, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.